obesity treatment
obesity treatment

€50 Million Boost for GLP-1 Production in France!
🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀

CordenPharma’s €900m Investment to Dominate Peptide Market
📢 CordenPharma invests €900m in peptide platform expansion, aiming to become a market leader and reach €1bn in sales by 2028. 🔬💊💪

Breakthrough Obesity Drug: 70 Achieve Over 15 Weight Loss
🌍 Roche's obesity drug CT-388 shows impressive results in clinical trial, offering hope for weight loss worldwide! 💊💪 ObesitySolution

Roche’s Breakthrough Obesity Drug: 188 Weight Loss!
🔍 Roche's CT-388 shows promising results in treating obesity, with a median weight loss of 18.8 in Phase I trial. 📈💊🩺

Spanish Company Acquires ALS Treatment for €1225m
🇪🇸 Spanish Ferrer Internacional, SA pays €122.5m for ALS candidate, VRG50635, with promising Phase I trial results. 💰🧪

Revolutionary Partnership Targets $80bn Obesity Treatment Market
🗞️ British companies Arecor Therapeutics and TRx Biosciences partner to develop an oral GLP-1 receptor agonist for obesity treatment. 🍔🍟💊💰💡

Breakthrough Treatment Prevents Blindness – BlueRock Leads the Way!
💼 Biotechnology company BlueRock aims to prevent blindness by commercializing a groundbreaking ocular disease treatment. 👀🌟

Revolutionary RSV Treatment Approved in China!
📝 AZ's Beyfortus authorized as first RSV treatment in China! 💊🇨🇳 Significant breakthrough in biotech industry. 👏😃







